7.75 USD
▼-0.08-1.02%
盘后 7.95 0.00%
2026-11-20
市值
$455.78M
市盈率
19.65
EPS
0.39
股息率
7.24%
52 周区间
6.60 – 9.35
成交量
47.05K
Beta
0.20
目标价
13.75
52W 低 6.6052W 高 9.35
价格走势
公司简介
Kamada Ltd. manufactures and sells plasma-derived protein therapeutics. Its products include KAMRAB/KEDRAB indicated as prophylaxis of rabies; CYTOGAM for prophylaxis of Cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplants; VARIZIG for post exposure prophylaxis of varicella; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; GLASSIA for intravenous AATD; KAMRHO (D) IM f...